inotuzumab ozogamicin

Ligand id: 8266

Name: inotuzumab ozogamicin

Immunopharmacology Comments
Inotuzumab ozogamicin is an immuno-oncology drug that blocks the inhibitory SIGLEC-2/sialic acid-containing glycans B cell checkpoint, an action that restores immune cell activation, and simultaneously delivers a toxic payload to CD-22-targeted cancer cells.
Immunopharmacology Disease
Disease X-Refs Comment References
Acute lymphocytic leukemia (ALL) OMIM: 613065
Approved therapy for ALL.